Adage Capital Partners
KYNB

Adage Capital Partners’s Kyntra Bio KYNB Stock Holding History

Adage Capital Partners’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-34,000
Closed -$15.9M – 886
2023
Q1 		$15.9M Sell
34,000
-72,000
-68% -$38.1M 0.04% 495
2022
Q4 		$42.5M Sell
106,000
-4,000
-4% -$1.53M 0.1% 238
2022
Q3 		$35.8M Buy
+110,000
New +$35.4M 0.09% 250
2020
Q3 		– Sell
-2,000
Closed -$2.03M – 778
2020
Q2 		$2.03M Hold
2,000
– – 0.01% 684
2020
Q1 		$1.74M Buy
+2,000
New +$1.99M 0.01% 660
2019
Q4 		– Sell
-60,000
Closed -$55.5M – 728
2019
Q3 		$55.5M Sell
60,000
-8,000
-12% -$8.79M 0.14% 189
2019
Q2 		$76.8M Buy
68,000
+26,000
+62% +$28.5M 0.19% 136
2019
Q1 		$57.1M Sell
42,000
-2,000
-5% -$2.71M 0.14% 177
2018
Q4 		$50.9M Buy
44,000
+24,280
+123% +$27.3M 0.14% 181
2018
Q3 		$29.9M Sell
19,720
-4,000
-17% -$6.16M 0.07% 313
2018
Q2 		$37.1M Sell
23,720
-8,280
-26% -$10.8M 0.09% 268
2018
Q1 		$37M Sell
32,000
-14,596
-31% -$19.2M 0.09% 278
2017
Q4 		$55.2M Buy
46,596
+3,000
+7% +$3.76M 0.12% 210
2017
Q3 		$58.6M Sell
43,596
-1,204
-3% -$1.27M 0.14% 196
2017
Q2 		$36.2M Buy
44,800
+5,800
+15% +$4.04M 0.09% 296
2017
Q1 		$24M Buy
39,000
+8,600
+28% +$5.24M 0.06% 366
2016
Q4 		$16.3M Sell
30,400
-30,000
-50% -$15M 0.04% 416
2016
Q3 		$31.3M Sell
60,400
-8,000
-12% -$3.77M 0.09% 307
2016
Q2 		$28.1M Sell
68,400
-2,000
-3% -$916K 0.08% 296
2016
Q1 		$37.5M Sell
70,400
-12,000
-15% -$5.98M 0.1% 234
2015
Q4 		$62.8M Sell
82,400
-11,348
-12% -$7.53M 0.16% 166
2015
Q3 		$51.4M Sell
93,748
-7,347
-7% -$4.45M 0.14% 191
2015
Q2 		$59.4M Buy
101,095
+1,380
+1% +$803K 0.15% 195
2015
Q1 		$78.2M Hold
99,715
– – 0.19% 154
2014
Q4 		$68.2M Buy
+99,715
New +$64.2M 0.17% 165

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Adage Capital Partners's KYNB Position: Q2 2023 in Review

Adage Capital Partners sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 34,000 shares — an estimated $15.9M sold.

Adage Capital Partners first reported a position in KYNB in Q4 2014 and held it in 25 quarters. The position peaked at $78.2M in Q1 2015. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Adage Capital Partners reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Adage Capital Partners sold 34,000 Kyntra Bio shares in Q2 2023, an estimated $15.9M.
  • Adage Capital Partners first reported a position in Kyntra Bio in Q4 2014 and held it in 25 quarters.
  • Adage Capital Partners's Kyntra Bio position peaked at $78.2M in Q1 2015.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Adage Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.